Hostname: page-component-76fb5796d-25wd4 Total loading time: 0 Render date: 2024-04-29T07:18:26.962Z Has data issue: false hasContentIssue false
  • English
  • Français

On the Discounting of Gained life-Years in Cost-Effectiveness Analysis

Published online by Cambridge University Press:  14 October 2009

Magnus Johannesson
Magnus Johannesson
Affiliation:
Stockholm School of Economics
Get access Rights & Permissions [Opens in a new window]

Abstract

A controversial issue in cost-effectiveness analysis is the discounting of gained life-years. What has not been realized, however, is that the different methods used for discounting this measurement provide fundamentally different results. The method used is seldom explicitly stated. In the present article the four main methods for the discounting of gained life-years are reviewed and compared. The conclusion is that if we wish to continue comparing results, researchers must employ the same methodology.

Type
Research Notes
Information
International Journal of Technology Assessment in Health Care , Volume 8 , Issue 2 , Spring 1992 , pp. 359 - 364
Copyright
Copyright © Cambridge University Press 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Christiansen, T., Pedersen, K. L., Harvald, B., et al. A health economic investigation of the effect of treatment for hypertension. Odense University: Research report No. 6, 1987.Google Scholar
2.Christiansen, T., Pedersen, K. L., Harvald, B., et al. An investigation of the effect of regional variation in the treatment of hypertension, Social Science and Medicine, 1989, 28, 131–39.Google Scholar
3.Drummond, M. F., Stoddard, G. L., & Torrance, G. W.Methods for the economic evaluation of health care programmes. Oxford: Oxford Medical Publications, 1987.Google Scholar
4.Jönsson, B., Horisberger, B., Bruguera, M., & Matter, L.Cost-benefit analysis of hepatitis-B vaccination: A computerized model for Spain. International Journal of Technology Assessment in Health Care, 1991, 7, 379–402.CrossRefGoogle ScholarPubMed
5.Keeler, E. B., & Cretin, S.Discounting of life-saving and other nonmonetary effects, Management Science, 1983, 29, 300–306.CrossRefGoogle Scholar
6.Kinosian, B. P., & Eisenberg, J. M.Cutting into cholesterol: Cost-effective alternatives for treating hypercholesterolemia. Journal of the American Medical Association, 1988, 259, 2249–54.Google Scholar
7.Rosen, S.The value of changes in life expectancy. Journal of Risk and Uncertainty, 1988, 1, 285–304.CrossRefGoogle Scholar
8.Statistics Sweden. Statistical abstract of Sweden 1988, Stockholm: Norstedts, 1987.Google Scholar
9.Waaler, H., Helgeland, A., Hjort, P., et al. Hoyt blodtrykk: Behandlingsprogram, utbytte, kostnader. Norges allmenvitenskapelige forskningsrads gruppe for helsetjensteforskning, Rapport Nr. 5, 1978.Google Scholar
10.Weinstein, M. C., & Stason, W. B.Hypertension: A policy perspective. Cambridge, MA: Harvard University Press, 1976.Google Scholar
11.Weinstein, M. C., & Stason, W. B.Foundations of cost-effectiveness analysis for health and medical practices. New England Journal of Medicine, 1977, 296, 732–39.Google Scholar
12.Weinstein, M. C., & Stason, W. B.Cost-effectiveness of interventions to prevent or treat coronary heart disease. Annual Review of Public Health, 1985, 6, 41–63.Google Scholar